Market research
0503.HK Lansen Pharmaceutical Holdings Limited
HK HKD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 751M
- P/E ratio
- 13.77
- Analyst target
- 0.4
- Dividend yield
- 0.5%
- Beta
- 0.92
Community
Investor discussion
1 comment
Sign in to join the 0503.HK discussion.
5 years, 5 months ago
Lansen Pharmaceutical Holdings Limited is currently in a long term uptrend where the price is trading 67.0% above its 200 day moving average.
From a valuation standpoint, the stock is 98.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.6.
Lansen Pharmaceutical Holdings Limited's total revenue sank by 4.7% to $27M since the same quarter in the previous year.
Its net income has increased by 610.9% to $96M since the same quarter in the previous year.
Finally, its free cash flow grew by 302.3% to $3M since the same quarter in the previous year.
Based on the above factors, Lansen Pharmaceutical Holdings Limited gets an overall score of 4/5.